课题基金 / 基金详情

An international randomized trial on neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma versus definitive chemoradiotherapy with salvage surgery as needed - The NEEDS Trial

An international randomized trial on neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma versus definitive chemoradiotherapy with salvage surgery as needed - The NEEDS Trial
一项关于食管鳞状细胞癌新辅助放化疗与根据需要进行挽救性手术的根治性放化疗的国际随机试验 - NEEDS 试验
批准号：
469430
负责人：
Lukovic Jelena
金额：
$132.08万
依托单位：
Princess Margaret Cancer Centre (Toronto)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-09-01 至 2030-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=469430&lang=en
关键词：
Esophagectomy Radiotherapy Randomized Trial Squamous Cell Carcinoma Esophagus

项目摘要

项目成果

Lukovic Jelena的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Esophageal cancer is the 6th leading cause of cancer death worldwide. Curative treatment for esophageal squamous cell carcinoma (ESCC), representing 90% of cases globally, is controversial. Candidates for surgery are preferably treated with chemoradiother
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金